Morphogenesis, Inc. Signs Cancer Treatment Deal with Novartis Animal Health Inc.
Tampa Bay Business Journal -- Morphogenesis Inc. and Novartis Animal Health have agreed to collaborate on development and commercialization of an investigational immunotherapy treatment for cancer in dogs.